Study guide
4.1 Negative Pressure Wound Therapy (NPWT) Indications, Settings, & Precautions
NAWCCB WCC Wound Care Certified Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
About the NAWCCB WCC Exam How to Use This Study Guide
2 Assessment: Skin & Tissue Foundations
1.1 Skin Anatomy, Physiology, and Barrier Function 1.2 Phases of Wound Healing & Cellular Events 1.3 Acute vs. Chronic Wounds & Etiology Classification 1.4 TIME and MEASURE Assessment Frameworks 1.5 Wound Bed Tissue Types & Periwound Assessment 1.6 Pain Assessment: Scales, Wound Pain Types, and Procedural Analgesia 1.7 Psychosocial History, Cognitive Status, and Functional Assessment 1.8 Skin Integrity Across the Lifespan: Neonatal, Pediatric, Adult, and Geriatric
3 Assessment: Diagnostic Tools & Risk Assessment
2.1 Vascular Assessment: ABI, TcPO2, and Arterial/Venous Doppler 2.2 Neuropathy & Monofilament Testing in Diabetic Patients 2.3 Pressure Injury Risk Assessment: Braden Scale Subscales & Scoring 2.4 NPIAP Pressure Injury Staging (Stages 1-4, Unstageable, DTPI) 2.5 Exudate Characterization, Biofilm (NERDS/STONEES), & Wound Culture 2.6 Laboratory Interpretation in Wound Care: Albumin, Prealbumin, ESR, A1C, CBC, and CMP 2.7 Risk Assessment Instruments Beyond Braden: Norton, Braden Q, Braden QD, Wagner, and University of Texas
4 Treatment: Dressing Selection & Debridement Modalities
3.1 Principles of Dressing Selection by Exudate & Moisture Balance 3.2 High-Absorbency Dressings: Alginates, Hydrofibers, and Foams 3.3 Barrier & Hydrating Dressings: Hydrocolloids, Transparent Films, and Hydrogels 3.4 Antimicrobial & Biofilm Dressings: Silver, Cadexomer Iodine, and Honey 3.5 Debridement Modalities: Sharp, Enzymatic, Autolytic, Mechanical, & Biosurgical
5 Treatment: Advanced Therapies & Specialized Management
4.1 Negative Pressure Wound Therapy (NPWT) Indications, Settings, & Precautions 4.2 Compression Therapy Protocols & ABI Safety Cutoffs 4.3 DFU Off-loading Hierarchy: TCC, RCW, and Therapeutic Footwear 4.4 Support Surfaces, Microclimate Control, & Repositioning Protocols 4.5 Advanced Biologics, Cellular/Tissue Products (CTPs), & HBOT
6 Reevaluation & Wound Healing Trajectory
5.1 Healing Trajectory Benchmarks & Percent Area Reduction (PAR) 5.2 Serial Wound Measurement, Depth Profiling, & Digital Photography 5.3 Treatment Plan Reassessment & Non-Healing Wound Escalation Triggers 5.4 Biofilm Progression & Systemic Infection Re-evaluation 5.5 Palliative Wound Management: Odor, Exudate, and Pain Control 5.6 Validated Healing Instruments: The PUSH Tool, BWAT, and Evaluating Adherence
7 Risk Reduction & Prevention Strategies
6.1 Pressure Injury Prevention: Bundles, Turning Schedules, & Heel Floating 6.2 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis (IAD) 6.3 Infection Control, Contact Precautions, & Environmental Hygiene 6.4 Prevention of Skin Tears & Medical Adhesive-Related Skin Injuries (MARSI) 6.5 Diabetic & Venous Ulcer Recurrence Prevention Protocols 6.6 At-Risk Populations: Spinal Cord Injury, Stroke, Critical Care, and Cognitive Impairment
8 Patient & Caregiver Education
7.1 Patient & Caregiver Wound Care Teaching & Self-Management 7.2 Diabetic Foot Self-Inspection & Footwear Education 7.3 Nutritional Assessment & Dietary Interventions for Wound Healing 7.4 Off-loading Compliance & Patient Mobility Education 7.5 Recognizing Complications, Infection Signs, & When to Seek Care 7.6 Educating the Interprofessional Team & Developing Educational Media
9 Administration & Program Management
8.1 Wound Care Documentation Standards & Clinical Records 8.2 Admission Wound Screening & Present on Admission (POA) Documentation 8.3 Interdisciplinary Team Roles & Clinical Care Coordination 8.4 Quality Improvement Metrics & HAPI Tracking Programs 8.5 Wound Care Formulary Management & Resource Utilization
10 Legal, Ethical, & Scope of Practice
9.1 Informed Consent, Treatment Refusal, & Autonomy in Wound Care 9.2 HIPAA Compliance & Clinical Photography Privacy Standards 9.3 Scope of Practice Across WCC-Eligible Professions (RN, LPN, PT, OT, DPM, MD/DO, PA) 9.4 HAPI Malpractice Liability & Documentation Defense 9.5 Ethical Considerations in Non-Healing Wounds & End-of-Life Skin Care 9.6 Regulatory Compliance, Coding Standards, & Audit Protection
4.1 Negative Pressure Wound Therapy (NPWT) Indications, Settings, & Precautions
Key Takeaways Explain This Topic AI
Standard subatmospheric pressure for NPWT is -125 mmHg continuous mode, which optimizes tissue granulation, wound contraction, and fluid removal.
Black reticulated polyurethane foam (400–600 μm pore size) promotes robust granulation and macrostrain, whereas white polyvinyl alcohol (PVA) non-adherent foam is denser, restricts tissue ingrowth, and protects exposed tendons, bone, or tunneling.
Absolute contraindications for NPWT include necrotic tissue with eschar present, untreated osteomyelitis, non-enteric or unexplored fistulas, exposed organs or major blood vessels, and active malignancy in the wound bed.
NPWT dressing changes are routinely performed every 48 to 72 hours for clean wounds, but frequency increases to every 24 hours in infected wounds.
In the event of active bleeding or sudden frank blood collection in the NPWT tubing/canister, the pump must be immediately disconnected, pressure turned off, and direct pressure applied to the wound site.
Last updated: August 2026
Negative Pressure Wound Therapy (NPWT) Indications, Settings, & Precautions
Negative Pressure Wound Therapy (NPWT), also known as vacuum-assisted closure, is an advanced therapeutic modality that applies controlled subatmospheric pressure to a wound bed through a sealed interface. By introducing negative pressure across the wound environment, NPWT transforms local biomechanical conditions, accelerates granulation tissue formation, and facilitates primary or secondary closure in complex, non-healing acute and chronic wounds.
Physiological Mechanics of NPWT
The therapeutic efficacy of NPWT relies on four primary physiological mechanisms operating simultaneously within the wound bed:
Macrostrain (Wound Contraction): The application of negative pressure draws the wound margins together, physically reducing wound surface area and volume.
Microstrain (Cellular Microdeformation): Subatmospheric pressure exerts mechanical shear forces on microscopic cell membranes. This cellular stretch induces mechanotransduction, stimulating intracellular signaling cascades, cell proliferation, protein synthesis, and rapid mitotic division of fibroblasts and vascular endothelial cells.
Exudate Management & Edema Reduction: Continuous evacuation of excess interstitial fluid decreases localized tissue edema. Reducing tissue pressure decompresses microvascular capillary beds, restoring local arterial microcirculation, oxygen delivery, and nutrient supply.
Bacterial Load & Protease Evacuation: Continuous suction removes wound exudate laden with matrix metalloproteinases (MMPs), inflammatory cytokines, and planktonic bacteria, shifting the chronic wound out of a persistent inflammatory state.
Pressure Settings & Operational Modes
Clinical selection of negative pressure levels and delivery modes must be customized based on wound etiology, tissue fragility, exudate volume, and patient pain tolerance.
Pressure Settings
Standard Default Pressure (-125 mmHg): The industry standard baseline pressure for the vast majority of acute, surgical, and chronic wounds. Research demonstrates that -125 mmHg provides optimal microvascular blood flow enhancement and granulation tissue production.
Low Pressure Range (-75 to -100 mmHg): Indicated for patients with fragile microvasculature, compromised peripheral arterial perfusion, skin grafts, delicate meshed grafts, painful wound beds, or when using dense white foam.
High Pressure Range (-150 to -175 mmHg): Reserved for large, deep wounds with copious, heavy exudate, extensive undermining, or large surgical dehiscent cavities requiring aggressive fluid evacuation.
Operational Modes
Continuous Mode (Default): Delivers a constant negative pressure throughout therapy. Continuous mode is mandated for the first 48 hours of therapy, in painful wounds, for meshed skin grafts, or when tunneling/undermining is present to ensure mechanical stability of the dressing seal.
Intermittent / Variable Mode: Cycles between a preset negative pressure (e.g., -125 mmHg for 5 minutes) and lower or zero pressure (e.g., 0 to -25 mmHg for 2 minutes). Intermittent therapy induces higher rates of cellular proliferation and granulation tissue formation than continuous pressure; however, cyclic pressure changes cause significantly increased discomfort and are contraindicated over tunnels or fresh skin grafts.
Dressing Selection: Black Foam vs. White Foam
Matching dressing material to tissue characteristics inside the wound bed is vital to prevent tissue damage and optimize healing outcomes.
Dressing Characteristic Black Polyurethane (PU) Foam White Polyvinyl Alcohol (PVA) Foam Non-Adherent Contact Layer
Material Structure Reticulated open-cell foam (400–600 μm pore size) Dense, hydrophobic/hydrophilic micro-porous foam Silicone or petroleum-impregnated mesh
Tensile & Flow Properties Highly flexible, hydrophobic; high exudate flow rate High tensile strength, moisture-retaining, semi-rigid Flexible, non-adherent barrier
Primary Mechanism Maximize macrostrain contraction and rapid granulation Restrict tissue ingrowth; uniform pressure delivery Protect underlying delicate structures
Clinical Indications Deep cavity wounds, sternal wounds, clean surgical dehiscent wounds Exposed tendon, bone, nerve, joint capsule; narrow tunnels/tracts Place under black foam over exposed vital structures
Removal Characteristics Tissue ingrowth occurs; can cause pain during change Smooth removal; minimal adherence to healing tissue Painless interface; prevents tissue mechanical tear
Absolute Contraindications & Precautions
NPWT carries significant risk if applied inappropriately. Clinicians must conduct a thorough safety audit prior to initiating therapy.
Absolute Contraindications
Necrotic Tissue with Eschar: NPWT cannot extract exudate through rigid eschar, and applying negative pressure over dry necrotic tissue increases anaerobic bacterial proliferation. Wounds must undergo thorough debridement to remove all devitalized tissue before NPWT placement.
Untreated Osteomyelitis: Applying NPWT over infected, un-debrided bone traps bacterial infection deep within the bony matrix, accelerating destruction.
Non-Enteric or Unexplored Fistulas: Placing NPWT over an unexplored fistula can cause massive organ rupture or uncontrolled fluid shifts.
Exposed Vital Organs, Blood Vessels, or Vascular Grafts: Direct foam contact with exposed arteries, veins, or internal organs carries a catastrophic risk of erosion, wall rupture, and fatal exsanguination.
Active Malignancy in the Wound Bed: Mechanical microdeformation and microvascular stimulation enhance tumor cell mitosis and metastatic dissemination.
High-Risk Precautions
Anticoagulant Therapy & Active Hemostasis Risk: Patients receiving therapeutic anticoagulation or presenting with friable periwound vessels require placement of a non-adherent protective contact layer (e.g., silicone interface) between the wound bed and foam.
Enteric Fistulas: Requires specialized low-pressure instillation systems managed by expert surgical teams.
Advanced NPWT Modalities: Instillation Therapy (NPWTi-d)
Negative Pressure Wound Therapy with Instillation and Dwell (NPWTi-d) combines automated instillation of topical wound cleansing solutions (e.g., normal saline, 0.125% sodium hypochlorite, hypochlorous acid) with traditional negative pressure:
Cycle Mechanics: The system instills a pre-determined volume of solution into the wound bed, allows it to dwell for a specified duration (typically 10 to 20 minutes) to loosen cellular debris and solubilize bacterial biofilm, and then evacuates the fluid under negative pressure for 2 to 4 hours before repeating the cycle.
Indications: Contaminated wounds, dirty surgical wounds, wounds with high bacterial bioburden, or post-debridement infected wound beds.
Dressing Change Schedules & Emergency Troubleshooting
Dressing Change Frequency: Standard dressing changes occur every 48 to 72 hours . In heavily infected wounds, dressing changes increase to every 24 hours . Clean wounds utilizing white PVA foam may extend up to 72 to 96 hours.
Managing Vacuum Leaks: Air leaks compromise pressure delivery and cause foam drying. Clinicians should smooth out drape wrinkles, seal seal borders with hydrocolloid strips or stoma paste, and verify tubing connections.
Emergency Bleeding Management: If sudden frank blood appears in the tubing or canister, immediately turn off the NPWT pump, disconnect the tubing, leave the dressing intact, and apply firm, direct pressure over the wound bed while calling emergency medical services or the surgical team.
- Parameter Standard Black Foam White PVA Foam NPWT with Instillation (NPWTi-d)
- Default Pressure -125 mmHg continuous -125 to -150 mmHg continuous -125 mmHg during suction cycle
Primary Function Rapid granulation & contraction Tissue protection & tunnel packing Biofilm removal & automated cleansing
- Dressing Change Every 48–72 hours Every 48–72 hours (up to 96 hours) Every 24–48 hours
- Pore Structure Open-cell (400–600 μm) Micro-porous, dense Open-cell foam with reticulated layer
Contraindications Eschar, malignancy, exposed vessels Eschar, malignancy, exposed vessels Non-enteric fistulas, untreated osteomyelitis